Close

content

Gilead presents additional data on investigational antiviral remdesivir to treat COVID-19 at Virtual COVID-19 Conference

Gilead Sciences Inc, announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to the available body of knowledge on...

Glenmark reduces price of oral antiviral FabiFlu by 27% in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a post marketing surveillance (PMS) study on FabiFlu to closely...

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies...

ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution

Powder containment and sterile transfer solutions experts, ChargePoint Technology, announced that it has entered into a collaboration with STERIS, a leading provider of infection...

Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API

Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, an active pharmaceutical ingredient...

Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies

Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), announces that it...

cGMP Compliance: Rules to safeguarding patient well-being

cGMP, which means ‘current Good Manufacturing Practice’, is a key component of the pharmaceutical industry and outlines the requirements necessary for ensuring the quality...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read